Cargando…

Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives

The human gut microbiota is the community of microorganisms living in the human gut. This microbial ecosystem contains bacteria beneficial to their host and plays important roles in human physiology, participating in energy harvest from indigestible fiber, vitamin synthesis, and regulation of the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsimichas, Themistoklis, Theofilis, Panagiotis, Tsioufis, Konstantinos, Tousoulis, Dimitris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963624/ https://www.ncbi.nlm.nih.gov/pubmed/36837875 http://dx.doi.org/10.3390/metabo13020256

Ejemplares similares

The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches
por: Tsioufis, Panagiotis, et al.
Publicado: (2022)

Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
por: Dimitroglou, Yannis, et al.
Publicado: (2023)

Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Pathophysiology of Acute Coronary Syndromes—Diagnostic and Treatment Considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target
por: Sagris, Marios, et al.
Publicado: (2022)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
por: Sagris, Marios, et al.
Publicado: (2021)

Inflammation in Coronary Microvascular Dysfunction
por: Sagris, Marios, et al.
Publicado: (2021)

Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
por: Theofilis, Panagiotis, et al.
Publicado: (2021)

Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
por: Sagris, Marios, et al.
Publicado: (2022)

Current Concepts and Future Applications of Non-Invasive Functional and Anatomical Evaluation of Coronary Artery Disease
por: Oikonomou, Evangelos, et al.
Publicado: (2022)

Inflammatory Mechanisms Contributing to Endothelial Dysfunction
por: Theofilis, Panagiotis, et al.
Publicado: (2021)

The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Inflammatory Mediators of Endothelial Dysfunction
por: Dri, Eirini, et al.
Publicado: (2023)

The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy
por: Angelopoulos, Andreas, et al.
Publicado: (2023)

Rationale and Design of a Randomized Controlled Clinical Trial on the Safety and Efficacy of Flecainide versus Amiodarone in the Cardioversion of Atrial Fibrillation at the Emergency Department in Patients with Coronary Artery Disease (FLECA-ED)
por: Tsioufis, Panagiotis, et al.
Publicado: (2023)

The association of Restless Legs Syndrome with hypertension and cardiovascular disease
por: Katsi, Vasiliki, et al.
Publicado: (2014)

Exploring the Impact of Cyanidin-3-Glucoside on Inflammatory Bowel Diseases: Investigating New Mechanisms for Emerging Interventions
por: Frountzas, Maximos, et al.
Publicado: (2023)

Diabetes Mellitus in Acute Coronary Syndrome
por: Stampouloglou, Panagiota K., et al.
Publicado: (2023)

Overview of coronary artery variants, aberrations and anomalies
por: Kastellanos, Stylianos, et al.
Publicado: (2018)

Gut Microbiota and Environment in Coronary Artery Disease
por: Piccioni, Andrea, et al.
Publicado: (2021)

Endothelial dysfunction in convalescent COVID-19 patients: Systematic review and meta-analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
por: Sagris, Marios, et al.
Publicado: (2021)

Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome
por: Katsioupa, Maria, et al.
Publicado: (2023)

Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment
por: Leopoulou, Marianna, et al.
Publicado: (2023)

The Effect of MicroRNA-126 Mimic Administration on Vascular Perfusion Recovery in an Animal Model of Hind Limb Ischemia
por: Theofilis, Panagiotis, et al.
Publicado: (2021)

Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis
por: Sagris, Marios, et al.
Publicado: (2022)

Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives
por: Dimitroglou, Yannis, et al.
Publicado: (2019)

Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia
por: Valatsou, Angeliki, et al.
Publicado: (2022)

Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease
por: Kallikazaros, Ioannis, et al.
Publicado: (2008)

P1668: NON-APOPTOTIC CIRCULATING MICROPARTICLES ARE INVERSELY ASSOCIATED WITH PROCOAGULANT BIOMARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES
por: Pallantza, Zoi, et al.
Publicado: (2023)

Arterial Hypertension and Health-Related Quality of Life
por: Katsi, Vasiliki, et al.
Publicado: (2017)

To the Editor — Are we close to a major impact on prevention of sudden cardiac death among coronary artery disease patients?
por: Doundoulakis, Ioannis, et al.
Publicado: (2022)

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
por: Burcelin, Rémy, et al.
Publicado: (2011)

Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
por: Lampsas, Stamatios, et al.
Publicado: (2023)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2p9j8dmphucvmv5hq0bhu207to